InsiderDB
Sign inStart free trial

Rep. Josh Gottheimer sold BioCryst Pharmaceuticals (BCRX)

Rep. Josh Gottheimer (D-NJ-5) · $1K–$15K · traded Sep 15, 2023

Transaction
Sold
Amount
$1K–$15K
Owner
Joint
Traded
Sep 15, 2023
Disclosed
Oct 15, 2023
Days to disclose
30
Asset type
Stock
As filed
BioCryst Pharmaceuticals, Inc.
Industry
Biotechnology · Healthcare
Official filing ↗All of Gottheimer's tradesAll Congress trades in BCRX

Other trades in this filing

All of Gottheimer's trades →

Recent Congress trades in BCRX

Company context for BCRX

Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.

  1. BCRXContract award·USAspending

    BCRX: Department of Veterans Affairs contract award

    ORLADEYO 150MG CAP

    First observed: Nov 8, 2026, 6:14 PM ESTEvent / period: May 19, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  2. BCRXContract award·USAspending

    BCRX: Department of Veterans Affairs contract award

    EMERGENCY ORLADEYO

    First observed: Nov 8, 2026, 6:14 PM ESTEvent / period: May 21, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  3. BCRXFinancial report·SEC EDGAR

    BCRX: 10-Q financial filing

    Filed 10-Q for an event or period dated 2026-09-30. Read the company report for its disclosures.

    Public: Nov 4, 2026, 4:04 PM ESTEvent / period: Sep 30, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.